FMS

Key Takeaways

• Dialysis is one of the rare businesses where a single company can build the machine, run the clinic the machine sits in and, in a growing slice of its U.S. work, take the insurance risk on the patient using it, and Fresenius Medical Care does all three across 3,539 clinics treating roughly 290,000 people [Source: FME press release, May 28, 2026]. • The prices are largely not its own to set: the FY2025 annual report states ⟦"A major portion of our revenues from healthcare are subject to reimbur

Institutional ownership

216 institutional managers reported holding FMS in 13F filings for the quarter ended 2026-03-31. Together they hold about 7% of the company; the top 10 hold 6%. 39 opened new positions that quarter. Held by Pzena Investment Management, Dodge & Cox, Morgan Stanley, among others. On the short side, 2.8M shares were sold short as of the 2026-06-15 count, about 0.5% of shares outstanding (3.6 days of typical volume to cover).

Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.

Capital returns

FMS's share count is about flat over the past five years. It pays a dividend, and has for 7 years running, raised 2 years straight; the current rate is $0.40 a share annually. Cash returned over the past three years: $838.78M in dividends.

Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.

Compare FMS

BTSG vs FMSCHE vs FMSCON vs FMSEHC vs FMSENSG vs FMSFMS vs NHC